Biologic therapies have transformed the management of psoriasis, but clinical outcome is
variable leaving an unmet clinical need for predictive biomarkers of response. Here we …

The development and use of biologic drugs, including ustekinumab, secukinumab, adalimumab
and newer anti-interleukin (IL)-23p19 biologics, have revolutionised treatment for the …

The development of biologics, including the anti-interleukin (IL)-12/IL-23p40 ustekinumab
and the anti-IL-17A secukinumab, has transformed the management of moderate-to-severe …

Introduction Uptake of preventive therapies for breast cancer is low. We examined whether
women at increased risk of breast cancer can be categorized into groups with similar …

IL-23-induced STAT3 translocation in MAIT cells at baseline is a candidate biomarker of response
for biologics targeting the IL-23/IL-17 axis Toggle navigation Login Toggle navigation …

Poor folate status during pregnancy can lead to elevated maternal plasma levels of
homocysteine (Hcy) with associated pregnancy complications and adverse neonatal outcomes, …

Hesx1 is a homeobox transcriptional repressor well known to be involved in the correct
specification and development of the forebrain and pituitary gland. Moreover, inactivating …

Dermatofibromas are benign, collagen-dense skin growths that can occur at any skin site.
Most dermatofibromas are solitary and sporadic; a few are multiple and familial. Despite …

Background Silver-Russell syndrome (SRS) is an imprinting disorder characterised by
prenatal and postnatal growth restriction, but its clinical features are non-specific and its …

Prenatal alcohol exposure (PAE) causes developmental abnormalities known as fetal alcohol
spectrum disorder (FASD). Maternal iron status modulates the severity of these defects in …